Ki-1 skin lymphoproliferative disorders: Management with radiation therapy

Cancer Investigation

Volumn 15, Issue 2, 1997, Pages 91-97

  Kaufmann, Thomas P ^a   Coleman, Morton ^a,b   Nisce, Lourdes Z ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MALE; PRIORITY JOURNAL; SKIN LYMPHOMA;

EID: 0030902018     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709115760     Document Type: Article

References (30)

1. Kadin ME: Characteristic immunologic profile of the large atypical cell in lymphomatoid papulosis. Possible implications for histogenesis and relationship to other diseases. Arch Dermatol 122:1388-1390, 1986.
2. Macaulay WL: Lymphomatoid papulosis. A continuing self healing eruption, clinically benign, histologically malignant. Arch Dermatol 97:23-30, 1968.
3. Sanchez NP, Pittelkow MR, Muller SA, et al: The clinicopathologic spectrum of lymphomatoid papulosis: Study of 31 cases. J Am Acad Dermatol 8:81-94, 1983.
4. Willemeze R. Lymphomatoid papulosis. Dermatol Clin 3:735-747, 1985.
5. Lange Wantzin G, Thomsen K, Larsen JK, et al: DNA by flow cytometry in lymphomatoid papulosis. Clin Exp Dermalol 8:505-512, 1983.
6. Verallo VM, Fand SB: DNA measurements in lymphomatoid papulosis: Evidence of this new entity. J Invest Dermatol 53:51-57, 1969.
7. Willemeze R, Meijer CJLM, Van Vloten, et al: The clinical and histological spectrum of lymphomatoid papulosis. Br J Dermatol 107:131-144, 1982.
8. Weinman VF, Ackerman AB: Lymphomatoid papulosis. A critical review and new findings. Am J Dermatopathol 3:129-163, 1981.
9. Sina B, Burnett JW: Lymphomatoid papulosis. Case reports and literature review. Arch Dermatol 119:189-197, 1983.
10. Stein H, Mason DY, Gerdes J, et al: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed Sternberg cells and hisliocytic malignancies are derived from activated lymphoid cells. Blood 66:848-858, 1982.
11. Chott A, Kaserer K, Augustin I, et al: Ki-1 positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 14:439-448, 1990.
12. Cabanillas F: Ki-1 Anaplastic large cell lymphoma. ASCO educational session 1991, pp. 159-160.
13. Beljaards RC, Meijer CLM, Scheffer E, et al: Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large cell lymphomas of T cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 135:1169-1178, 1989.
14. Kaudewitz P, Stein H, Dallenbach F, Eckert F, et al: Primary and secondary cutaneous Ki-1 (CD30) anaplastic large cell lymphomas. Morphologic, immunologic and clinical characteristics. Am J Pathol 135:359-367, 1989.
15. Offit K, Ladanyi M, Gangi MD, Ebrahim SA, Filippa D, Chaganti RS. Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625-630, 1990.
16. Willemeze R, Beljaards. Spectrum of primary CD 30 (Ki-1 )-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973-80, 1993.
17. Beljaards, Willemeze R: The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. Br J Dermatol 126:596-602, 1992.
18. Lange Wantzin G, Thomsen K: Methotrexate in lymphomatoid papulosis. Br J Dermatol 111:93-95, 1984.
19. Burg G, Klepzig K, Kaudewitz P, Wolff H, et al: Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA 256:214-215, 1986.
20. Baumgartner G, Duschet P, Schwanz T, et al: Lymphomatoid papulosis: Remission following intravenously administered acyclovir. Dermatologica 172:305-309, 1986.
21. Lange Wantzin G, Thomsen K:PUVA-treatment in lymphomatoid papulosis. Br J Dermatol 107:687-690,1982.
22. Wilson LD, Cooper DL, Goodrich AL, et al : Impact of non-CTCL dermatologie diagnosis and adjuvant therapies on cutaneous T cell lymphomas patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys 28:829-837, 1994.
23. Breneman J, Breneman D: Response of total skin irradiation to mycosis fungoides associated with lymphomatoid papulosis. Int J Radiat Oncol Bid Phys 32:274, 1995.
24. Wilson LD, Kacinski BM: In response to Drs. Breneman and Breneman. Int J Radiat Oncol Biol Phys 32:274, 1995 (letter).
25. Wood GS, Strickler JG, Deneau DG, et al: Lymphomaloid papulosis expresses immunophenotypes associated with T cell lymphoma bue no inflammation. J Am Acad Dermatol 15:444-458, 1986.
26. Kadin ME: Common activated helper-T-cell origin for lymphomatoid papulosis, mycosis fungoides, and some types of Hodgkin's disease. Lancet 2:864-865, 1985.
27. Kaufmann T, Nisce LZ, Silver R: Lymphomatoid papulosis: Case report of a patient managed wilh radiation therapy, and review of the literature. Am J Clin Oncol 15:412-416, 1992.
28. Nisce LZ, Safai B, Kirn JH: Electron beam therapy for mycosis fungoides. J Dermatol Surg Oncol 4:594-599, 1978.
29. Nisce LZ, D'Angio GJ: A new technique for the irradiation of large fields in patients with lymphoma. Radiology 106:641-644, 1973.
30. Nisce LZ, Chu FCH, Lee HS, Filipa D, Kempin S, Coleman M: Total skin electron beam therapy for cutaneous lymphomas and leukemias. Int J Radiat Oncol Biol Phys 8:1587-1592, 1982